HomeACTU • NASDAQ
add
Actuate Therapeutics Inc
Previous close
$7.60
Day range
$7.00 - $7.63
Year range
$5.47 - $11.99
Market cap
172.47M USD
Avg Volume
58.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.47M | 1.47% |
Net income | -5.41M | 9.44% |
Net profit margin | — | — |
Earnings per share | -0.25 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.92M | 25.15% |
Total assets | 17.71M | 24.20% |
Total liabilities | 6.78M | -23.88% |
Total equity | 10.94M | — |
Shares outstanding | 23.24M | — |
Price to book | 16.17 | — |
Return on assets | -110.85% | — |
Return on capital | -330.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.41M | 9.44% |
Cash from operations | -6.68M | 27.01% |
Cash from investing | — | — |
Cash from financing | 17.11M | -23.35% |
Net change in cash | 10.43M | -20.80% |
Free cash flow | -4.77M | 40.50% |
About
Founded
2015
Headquarters
Website
Employees
10
